|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 8 of 8
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Sawamura, Daisuke; Sakuraba, Satoshi; Suzuki, Yumi; Asano, Masako; Yoshida, Susumu; Honke, Toshihiro; Kimura, Megumi; Iwase, Yoshiaki; Horimoto, Yoshitaka; Yoshida, Kazuki; Sakai, Shinya | Acquisition of chopstick-operation skills with the non-dominant hand and concomitant changes in brain activity | - | Scientific reports | - | 31-Dec-2019 |
| article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma | - | JGH open | - | Oct-2020 |
| article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kubo, Akinori; Yamada, Ren; Furuya, Ken; Baba, Masaru; Kitagataya, Takashi; Suzuki, Kazuharu; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma | - | PLoS ONE | - | 1-Mar-2021 |
| article | Sho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, Naoya | Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting | - | JGH open | - | Feb-2020 |
| article (author version) | Suda, Goki; Kudo, Mineo; Nagasaka, Atsushi; Furuya, Ken; Yamamoto, Yoshiya; Kobayashi, Tomoe; Shinada, Keisuke; Tateyama, Miki; Konno, Jun; Tsukuda, Yoko; Yamasaki, Kazushi; Kimura, Megumi; Umemura, Machiko; Izumi, Takaaki; Tsunematsu, Seiji; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C | - | Journal of gastroenterology | - | Jul-2016 |
| article | Ohara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, Naoya | L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis | - | Hepatology communications | - | Aug-2018 |
| article | Kawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, Naoya | Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis | - | PLOS ONE | - | 2018 |
| article | Suda, Goki; Nakai, Masato; Sho, Takuya; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Baba, Masaru; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment | - | Internal medicine | - | 1-Apr-2019 |
Showing results 1 to 8 of 8
|
